SCHEMBL9891809

SCHEMBL9891809

CCC(C)c1ccc(NC(=O)C(C)C)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.66
NPSR1 Q6W5P4 3/20 0.62
RAB9A P51151 7/20 0.56
NPC1 O15118 5/20 0.56
MAPT P10636 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
NFKB1 P19838 1/20 0.56
NFKB2 Q00653 1/20 0.56
RELA Q04206 1/20 0.56
KMT2A Q03164 5/20 0.55
MEN1 O00255 4/20 0.55
ALDH1A1 P00352 4/20 0.54
RXFP1 Q9HBX9 1/20 0.54
TP53 P04637 1/20 0.54
CRHBP P24387 1/20 0.53
CRHR2 Q13324 1/20 0.53
GAA P10253 1/20 0.53
HPGD P15428 1/20 0.51
HTT P42858 1/20 0.51
CA12 O43570 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2097636 0.84 TSHR (0.68) TSHRNPSR1RAB9ANPC1MAPT
SCHEMBL2097639 0.84 TSHR (0.68) TSHRNPSR1RAB9ANPC1MAPT
SCHEMBL9893031 0.84 TSHR (0.73) TSHRNPSR1RAB9ANPC1MAPT
SCHEMBL8208063 0.83 TSHR (0.59) TSHRNPSR1RAB9ANPC1MAPT
SCHEMBL18880072 0.82 ALDH1A1 (0.73) NPSR1RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL14237971 0.82 TSHR (0.76) TSHRNPSR1RAB9ANPC1MAPT
SCHEMBL4979578 0.81 TSHR (0.60) TSHRNPSR1RAB9ANPC1MAPT
SCHEMBL103862 0.81 KMT2A (0.61) NPSR1RAB9AMAPTSMN1; SMN2NFKB1
SCHEMBL2091879 0.81 TSHR (0.64) TSHRNPSR1RAB9ANPC1MAPT
Hydrochloric Acid SCHEMBL4985012 0.80 TSHR (0.58) TSHRNPSR1RAB9ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8629157-B2 Pyrrolidine compounds which modulate the CB2 receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-01-14 US disclosed
US-20120142677-A1 Pyrrolidine Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-07 US disclosed
US-20120142677-A1 Pyrrolidine Compounds Which Modulate The CB2 Receptor BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142677-A1 Pyrrolidine Compounds Which Modulate The CB2 Receptor CNR2, CNR1, OPRL1 TSHR 1003/4885NPSR1 31/4885RAB9A 2299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.